Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs

Funding Agency:
National Institutes of Health

The National Center for Advancing Translational Sciences (NCATS) announces the early termination of NOT-TR-21-022, Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs. NCATS will not accept applications for competitive revisions in response to NOT-TR-21-022 effective immediately due to the end of the declared public health emergency as stated in NOT-OD-23-095 “Expiration of the COVID-19 Public Health Emergency”.

The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts by performing high-priority clinical studies and trials to test therapeutics for the Coronavirus Disease 2019 (COVID-19).

NCATS is soliciting applications for Emergency Competitive Revisions to Existing NIH Awards (through PA-20-135) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients for clinical studies and trials in support of COVID-19 therapeutic interventions as follows:

  • RFA-TR-15-002- CTSA Network - Trial Innovation Centers (TICs) (U24)
  • RFA-TR-15-004- Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs) (U24)
  • PAR-18-940 - Clinical and Translational Science Award (U54 Clinical Trial Optional) UL1 Component Only
  • PAR-18-464 - Clinical and Translational Science Award (U54 Clinical Trial Optional) UL1 Component Only
  • PAR-15-304 - Clinical and Translational Science Award (U54 Clinical Trial Optional) UL1 Component Only

NCATS expects to issue 1-8 awards for clinical studies and trials in support of COVID-19 therapeutic interventions.

Applications will be accepted immediately and on a rolling basis through August 16, 2024 by 5:00 PM local time of the applicant organization.

NOT-TR-21-022

Expiration Date: New Date June 22, 2023 (Original Date: August 17, 2024) per issuance of NOT-TR-23-024

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

June 22, 2023